bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: D N O S A J J M A M F J
2016: D

 
  Other news for:
Bites and Stings
Immunization
Pregnancy
Pregnancy Complications
 Resources from HONselect
Malaria Drug Protected Mouse Fetus From Zika: Study
More research is needed on effects in primates and humans, researcher says

By Robert Preidt

TUESDAY, July 11, 2017 (HealthDay News) -- A malaria drug protected mice fetuses from the Zika virus, researchers report.

In humans, Zika infection during pregnancy can cause severe brain damage in infants.

In this study with pregnant mice, investigators found that the malaria drug hydroxychloroquine prevented Zika from crossing the placenta.

"We found that the malaria drug hydroxychloroquine effectively blocks viral transmission to the fetus," said senior author Indira Mysorekar. She's an associate professor of obstetrics and gynecology, and of pathology and immunology at the Washington University School of Medicine in St. Louis.

"This drug already is used in pregnant women to treat malaria, and we suggest that it warrants evaluation in primates and women to diminish the risks of Zika infection and disease in developing fetuses," Mysorekar said in a school news release.

Even though hydroxychloroquine has been used safely in pregnant women for short periods of time, the researchers said further studies are needed before it can be used in pregnant women to protect their fetuses against Zika. Research involving animals often fails to produce similar results in humans.

Pregnant women living in areas with Zika may need to take the drug throughout their pregnancy. Right now, the long-term safety of the drug is unknown.

"We would urge caution but nevertheless feel our study provides new avenues for feasible therapeutic interventions," said Mysorekar, who is also co-director of the university's Center for Reproductive Health Sciences.

The study was published July 10 in The Journal of Experimental Medicine.

More information

The U.S. Centers for Disease Control and Prevention has more on Zika.

SOURCE: Washington University School of Medicine in St. Louis, news release, July 10, 2017

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=724440

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Fetus
Women
Research Personnel
Hydroxychloroquine
Bites and Stings
Infection
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Inicio img Sobre nosotros img Rincón de la prensa img Boletín HON img Mapa del sitio img Política ética img Contactos